Post Archive by Month

Authors found that BMI of ≥27 shows excellent diagnostic performance

Greater use of weight management treatments seen with WNP, including bariatric surgery, low-calorie meal replacement

Reduction seen in risk for clinically important kidney outcomes and death from cardiovascular causes

Areas with high incidence of delay characterized by increased social vulnerability including SES, housing type, and transportation

In a recent study, donors had initial drop in eGFR after nephrectomy, followed by lesser decline per year than nondonors

From 2007 to 2019, medical burden increased from 23.5 to 26.4 percent for low-income families and from 5.4 to 6.5 percent for higher-income families

Findings seen for men and women even at high volumes of aerobic leisure-time physical activity

Increased risk seen, especially for hypertensive disease; risk was apparent as early as 30 days postdelivery

Similar benefits seen for all-cause mortality and cardiovascular disease prevention

Second study shows cardiovascular benefit for semaglutide, regardless of weight loss